Company / SG&A per Share
ANAPTYSBIO, INC SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.66
FY2025
5-year range
$0.59 / $1.66
FY2021-FY2025
Trend
+4.5%
vs FY2024
Sector context
#90 of 210
Health Care
What the data says
At $1.66, ANAPTYSBIO, INC's sg&a per share ranks #121 of 210 in the Health Care sector. SG&A per Share has increased for 6 consecutive years, from $0.35 in FY2019 to $1.66 in FY2025.
Based on SEC 10-K filings.
1.66 in FY2025 with a 5-year CAGR of +23.9%.
Increased from $1.47 to $1.66 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +34.7%
- 5-Year CAGR
- +23.9%
- 10-Year CAGR
- -
Sector benchmark
#121 of 210 in Health CareTop 57% of 210This company $1.66 Sector average $40.75
▼
-95.9% below sector average
Key checks
Key Insights
- ANAPTYSBIO, INC's sg&a per share has grown for 6 consecutive years.
- In FY2025, sg&a per share increased 4.5% year-over-year.
- Ranks #90 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.66 | +4.5% |
| FY2024 | $1.59 | +8.3% |
| FY2023 | $1.47 | +115.7% |
| FY2022 | $0.68 | +15.9% |
| FY2021 | $0.59 | +3.3% |
| FY2020 | $0.57 | +64.2% |
| FY2019 | $0.35 | -44.9% |
| FY2018 | $0.63 | -53.5% |
| FY2017 | $1.35 | -16.8% |
| FY2016 | $1.63 | +15.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026